Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000404325) titled 'A randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of LactoSpore in perimenopausal women' on April 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Clinical Research Australia
Condition:
Vasomotor symptoms
Anxiety
Depressive symptoms
Sleep disturbance
Fatigue
Vasomotor symptoms
Anxiety
Depressive symptoms
Sleep disturbance
Fatigue
Reproductive Health and Childbirth - Menstruation and menopause
Menta...